Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
about
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesCellular Responses and Tissue Depots for Nanoformulated Antiretroviral TherapyNanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.Towards nanomedicines for neuroAIDS.Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesDJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine.Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.Investigational reverse transcriptase inhibitors for the treatment of HIV.Functional proteome of macrophage carried nanoformulated antiretroviral therapy demonstrates enhanced particle carrying capacityOvercoming pharmacologic sanctuaries.Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapyMacrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infectionsNanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous systemLong-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients.HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.Nano-ART and NeuroAIDS.Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.Safety, tolerability and pharmacokinetics of rilpivirine following administration of a long-acting formulation in healthy volunteers.Commentary: Animal models of neuroAIDS.Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.Hydrophobic-core PEGylated graft copolymer-stabilized nanoparticles composed of insoluble non-nucleoside reverse transcriptase inhibitors exhibit strong anti-HIV activity.Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlation.Interview: Nanomedicine and the fight against HIV/AIDS.
P2860
Q26850868-E2D3E542-ADAE-403F-BC62-5F29C8ECA241Q28551873-FEA4101F-7F8B-45F8-9580-E4434ABB1C3AQ30387307-6AF077CA-6589-4055-B1BE-77A4C75137CBQ33625213-7B7BA588-0DB1-478D-92E8-EB18442FF19DQ34495140-2BFE4526-98C6-4B65-A54C-F5A7A614DD24Q34726183-60E7B0D0-1E2F-4421-9231-109BBC5A3073Q34797004-12915707-6594-4232-96CD-E14FCE813763Q35895155-F934BF3F-31DB-4D74-88B3-80BCC2766F9BQ36093283-259AB285-9148-4F5F-919A-DDA0C8D5B1C7Q36306231-057989D3-0041-4560-BE5B-96ABA04BA012Q36875347-007B08F2-188F-405D-A518-39E88AC49E5BQ36915933-0523D29E-F731-4785-8F89-389BE5DBD754Q36969787-C929EE30-FBD3-4FE8-BBBA-B3BC210F0A25Q37188867-48F5024A-5E7B-44B2-95FC-0C3AD5C9702AQ37698620-E9A5C0F8-2E35-4AF0-BEB1-8DC997040651Q37704651-3F120BB8-49C6-4F07-A715-192D761EC437Q38725384-9C4D5048-0E21-4CAD-9B8F-140B76B504DEQ38738244-A831069E-8AC9-41F7-B8FE-3EF73C7B411BQ38823456-13E774FF-D933-4A4E-B262-8715BAFF1F21Q39004638-39067E5B-B699-4D39-9659-7BB8AC37AAACQ41219268-F51EC1F4-4EEE-4EDC-A41E-6855ED571B5DQ41850246-2053446F-C302-47C0-8213-2CA17A17860EQ41905223-96E9DA20-1B16-4C0F-AFDB-A2211D88B993Q42050799-BBFA63E0-AAD6-40F2-80E0-78E435686575Q46448056-886F3DE5-2683-4E5C-AD1E-C4EF73EB2791Q48375952-3AD3C9F5-1888-4DEA-BA30-A4EAA01AB284
P2860
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mononuclear phagocyte intercel ...... human brain endothelial cells.
@ast
Mononuclear phagocyte intercel ...... human brain endothelial cells.
@en
type
label
Mononuclear phagocyte intercel ...... human brain endothelial cells.
@ast
Mononuclear phagocyte intercel ...... human brain endothelial cells.
@en
prefLabel
Mononuclear phagocyte intercel ...... human brain endothelial cells.
@ast
Mononuclear phagocyte intercel ...... human brain endothelial cells.
@en
P2093
P2860
P356
P1476
Mononuclear phagocyte intercel ...... human brain endothelial cells.
@en
P2093
Alexander Kabanov
Georgette D Kanmogne
Howard E Gendelman
Joellyn McMillan
Larisa Poluektova
Nagsen Gautam
Nathan Smith
Sangya Singh
Santhi Gorantla
Shantanu Balkundi
P2860
P304
P356
10.2147/IJN.S29454
P407
P577
2012-05-08T00:00:00Z